Childhood cancer and the Jehovah's Witness faith. (otvorí nové okno)

Frankel LS, Damme CJ, Eys JV.

Zdroj‎: Pediatrics 1977;60(6):916-21.

Označenie‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (otvorí nové okno)

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children's Oncology Group trial AAML0531. (otvorí nové okno)

Gamis AS, Alonzo TA, Meshinchi S, Sung L, Gerbing RB, Raimondi SC, Hirsch BA, Kahwash SB, Heerema-McKenney A, Winter L, Glick K, Davies SM, Byron P, Smith FO, Aplenc R

Zdroj‎: J Clin Oncol 2014;32(27):3021-32.

Označenie‎: PubMed 25092781

Identifikátor digitálneho objektu‎: 10.1200/JCO.2014.55.3628

https://www.ncbi.nlm.nih.gov/pubmed/25092781 (otvorí nové okno)

Red blood cell transfusion and outcome in cancer. (otvorí nové okno)

Iqbal N, Haider K, Sundaram V, Radosevic J, Burnouf T, Seghatchian J, Goubran H

Zdroj‎: Transfus Apher Sci 2017;56(3):287-90.

Označenie‎: PubMed 28602484

Identifikátor digitálneho objektu‎: 10.1016/j.transci.2017.05.014

https://www.ncbi.nlm.nih.gov/pubmed/28602484 (otvorí nové okno)

Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases. (otvorí nové okno)

Oh SY, Kim SH, Kwon HC, Lee S, Kim KH, Kwon KA, Lee JH, Lee KY, Kim HJ

Zdroj‎: Support Care Cancer 2010;18(10):1341-6.

Označenie‎: PubMed 19841950

Identifikátor digitálneho objektu‎: 10.1007/s00520-009-0759-3

https://www.ncbi.nlm.nih.gov/pubmed/19841950 (otvorí nové okno)